Steris (STE) Depreciation & Amortization (CF) (2018 - 2026)
Steris (STE) recorded quarterly Depreciation & Amortization (CF) of $123.4 million in Q1 2026, up 1.15% quarter-over-quarter from $122.0 million in Q4 2025, and up 0.9% on a YoY basis from $122.3 million in Q1 2025.
Steris (STE) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Steris' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $123.4 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 0.9% year-over-year to $123.4 million; the TTM figure through Mar 2026 stood at $486.5 million (up 2.16% YoY), while the FY2026 annual figure was $486.5 million, up 2.16% from the prior year.
- Depreciation & Amortization (CF) was $123.4 million for Q1 2026 at Steris, up from $122.0 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $233.8 million in Q1 2022 to a low of $112.7 million in Q2 2024.
- Historically, Depreciation & Amortization (CF) has averaged $136.2 million across 5 years, with a median of $133.9 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) surged 296.03% in 2022, then plunged 39.19% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $138.0 million in 2022, then gained by 1.94% to $140.6 million in 2023, then declined by 10.47% to $125.9 million in 2024, then declined by 3.1% to $122.0 million in 2025, then increased by 1.15% to $123.4 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $123.4 million (Q1 2026), $122.0 million (Q4 2025), and $121.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 270.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.40 Mn |
| Mar 31, 2026 | 123.40 Mn |
| Dec 31, 2025 | 122.00 Mn |
| Dec 31, 2025 | 122.00 Mn |
| Sep 30, 2025 | 121.70 Mn |
| Sep 30, 2025 | 121.70 Mn |
| Jun 30, 2025 | 119.40 Mn |
| Jun 30, 2025 | 119.40 Mn |
| Mar 31, 2025 | 122.30 Mn |
| Mar 31, 2025 | 122.30 Mn |
| Dec 31, 2024 | 125.90 Mn |
| Dec 31, 2024 | 125.90 Mn |
| Sep 30, 2024 | 115.30 Mn |
| Sep 30, 2024 | 115.30 Mn |
| Jun 30, 2024 | 112.70 Mn |
| Jun 30, 2024 | 112.70 Mn |
| Mar 31, 2024 | 134.39 Mn |
| Mar 31, 2024 | 134.39 Mn |
| Dec 31, 2023 | 140.63 Mn |
| Dec 31, 2023 | 140.63 Mn |